We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M Turnover 32.67%
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+2.74%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$672M
AUM Growth
-$54.6M
Cap. Flow
-$44.7M
Cap. Flow %
-6.65%
Top 10 Hldgs %
16.18%
Holding
133
New
7
Increased
39
Reduced
67
Closed
6
Avg Time Held
1.7 years
Top 10 Avg Time Held
0.2 years
Top 20 Avg Time Held
0.3 years

Top Buys

Rank Stock Value
1
LEVI icon
Levi Strauss
LEVI
+$8.03M
2
RDDT icon
Reddit
RDDT
+$6.78M
3
BE icon
Bloom Energy
BE
+$5.83M
4
CART icon
Maplebear
CART
+$5.2M
5
KGS icon
Kodiak Gas Services
KGS
+$4.54M

Top Sells

Rank Stock Value
1
WING icon
Wingstop
WING
+$6.42M
2
MNDY icon
monday.com
MNDY
+$6.26M
3
QTWO icon
Q2 Holdings
QTWO
+$6.07M
4
RDNT icon
RadNet
RDNT
+$6.02M
5
FTI icon
TechnipFMC
FTI
+$5.67M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 21.35%
3 Industrials 16.36%
4 Consumer Discretionary 12.91%
5 Consumer Staples 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KGS icon
76
Kodiak Gas Services
KGS
$4.77B
$4.56M 0.68%
+167,212
New +$4.54M
2024 Q2
0 quarters
ROIV icon
77
Roivant Sciences
ROIV
$24.2B
$4.49M 0.67%
425,087
+96,905
+30% +$1.06M
2023 Q1
5 quarters
GLBE icon
78
Global E Online
GLBE
$6.52B
$4.46M 0.66%
123,014
-75,472
-38% -$2.44M
2023 Q1
5 quarters
ITCI icon
79
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.42M 0.66%
64,504
+10,050
+18% +$697K
2022 Q2
8 quarters
LSCC icon
80
Lattice Semiconductor
LSCC
$14.7B
$4.36M 0.65%
75,229
-6,221
-8% -$430K
2019 Q1
21 quarters
SKY icon
81
Champion Homes
SKY
$4.22B
$4.32M 0.64%
63,785
-44,680
-41% -$3.35M
2023 Q4
2 quarters
MMS icon
82
Maximus
MMS
$3.22B
$4.27M 0.64%
49,863
-56,589
-53% -$4.75M
2020 Q2
16 quarters
FIVN icon
83
FIVE9
FIVN
$2.41B
$4.22M 0.63%
95,605
-7,725
-7% -$401K
2022 Q2
8 quarters
GLOB icon
84
Globant
GLOB
$1.71B
$4.14M 0.62%
23,232
+23,178
+42,922% +$4.09M
2022 Q4
6 quarters
GPCR icon
85
Structure Therapeutics
GPCR
$1.5B
$3.97M 0.59%
101,204
+3,647
+4% +$150K
2023 Q4
2 quarters
DNLI icon
86
Denali Therapeutics
DNLI
$2.81B
$3.84M 0.57%
165,486
-6,845
-4% -$131K
2023 Q2
4 quarters
ADPT icon
87
Adaptive Biotechnologies
ADPT
$3.83B
$3.82M 0.57%
1,055,299
-48,142
-4% -$153K
2020 Q2
16 quarters
INMD icon
88
InMode
INMD
$815M
$3.46M 0.52%
189,886
-8,403
-4% -$154K
2023 Q4
2 quarters
AEHR icon
89
Aehr Test Systems
AEHR
$1.98B
$3.45M 0.51%
308,933
+189,369
+158% +$2.21M
2024 Q1
1 quarter
MRVI icon
90
Maravai LifeSciences
MRVI
$1.01B
$3.43M 0.51%
478,355
-27,940
-6% -$241K
2021 Q4
10 quarters
OPCH icon
91
Option Care Health
OPCH
$4.67B
$3.41M 0.51%
123,101
-114,429
-48% -$3.41M
2021 Q4
10 quarters
PGNY icon
92
Progyny
PGNY
$2.06B
$3.36M 0.5%
117,280
-2,260
-2% -$68.1K
2019 Q4
18 quarters
GH icon
93
Guardant Health
GH
$21.3B
$3.35M 0.5%
+115,854
New +$2.7M
2024 Q2
0 quarters
VKTX icon
94
Viking Therapeutics
VKTX
$3.2B
$3.03M 0.45%
57,239
-2,420
-4% -$159K
2024 Q1
1 quarter
IMCR icon
95
Immunocore
IMCR
$1.51B
$2.76M 0.41%
81,306
-6,748
-8% -$344K
2021 Q3
11 quarters
SITE icon
96
SiteOne Landscape Supply
SITE
$4.14B
$2.7M 0.4%
22,248
-987
-4% -$149K
2022 Q4
6 quarters
TEM icon
97
Tempus AI
TEM
$11.8B
$2.3M 0.34%
+65,741
New +$2.02M
2024 Q2
0 quarters
ALAB icon
98
Astera Labs
ALAB
$49.6B
$1.75M 0.26%
28,868
-529
-2% -$36.7K
2024 Q1
1 quarter
PINS icon
99
Pinterest
PINS
$12.4B
$1.17M 0.17%
26,611
+856
+3% +$33.7K
2019 Q2
20 quarters
TW icon
100
Tradeweb Markets
TW
$23.9B
$1.11M 0.17%
10,476
+336
+3% +$35.5K
2022 Q4
6 quarters

Similar funds

Pier Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Pier Capital held 133 positions worth $672M, down 7.5% from $727M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Pier Capital withdrew a net $44.7M in Q2 2024, closing 6 positions and reducing 67 holdings. Its most notable exit was Wingstop, an estimated $6.42M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Pier Capital opened a new position in Levi Strauss worth $7.07M.

  • Pier Capital's largest Q2 2024 buy was Levi Strauss: 366,451 shares worth $7.07M.
  • Pier Capital added most to Globant in Q2 2024, an estimated $4.09M increase.
  • Pier Capital's biggest Q2 2024 reduction was Q2 Holdings, cutting an estimated $6.07M.
  • Pier Capital fully exited Wingstop in Q2 2024, selling an estimated $6.42M.
  • Pier Capital's ten largest holdings make up 16% of its $672M portfolio in Q2 2024.
  • Pier Capital opened 7 new positions and closed 6 in Q2 2024.
  • Pier Capital's portfolio value fell 7.5% quarter-over-quarter to $672M.

Based on Pier Capital's 13F filing for Q2 2024, filed 7 Aug 2024.